John J. DiPietro
Financieel Directeur/CFO bij Chronix Biomedical, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Adel Karas | M | 79 | 17 jaar | |
| Wiiliam A. Boeger | M | - |
Chronix Biomedical, Inc.
 Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | 27 jaar |
| Kartlos Edilashvili | M | 50 | 17 jaar | |
| Paul Freiman | M | 89 |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | 13 jaar |
| Ekkehard Schütz | M | - |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | - |
| Robert D. Leppo | M | - |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | - |
| David R. MacKenzie | M | - |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | - |
| Mike Jerstad | M | - |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | - |
| Ralf Glaubitz | M | - |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jerrold Dotson | M | 71 | 8 jaar | |
| Richard C. Dietz | M | - | - | |
| Anthony Cataldo | M | 73 | 2 jaar | |
| Julius R. Krevans | M | 99 | 14 jaar | |
| Richard R. van Maanen | M | - | - | |
| Maxim A. Soulimov | M | 51 | 4 jaar | |
| Roger Ian Gale | M | 72 | 4 jaar | |
| Barbara T. McAleer | F | - | 2 jaar | |
| Theodore R. Gwin | M | - | 2 jaar | |
| Ronald William Mink | M | 71 | - | |
| Richard Brounstein | M | 74 | 6 jaar | |
| Neal J. Carney | M | 68 |
Tripath Technology, Inc.
 Tripath Technology, Inc. SemiconductorsElectronic Technology The Group's principal activities are to design and sell integrated circuit devices. The products of the Group are used in consumer audio applications such as DVD players, home theater systems, internet appliances, gaming consoles, computer audio applications. The Group also manufactures amplifiers that enable the manufacturers of these products in the elimination of externally-powered speakers and in improving overall sound quality. The Group serves consumer audio, personal computer and communications markets. The Group markets and sells its products through its regional offices located in Japan, Hong Kong, as well as through representatives and independent distributors in Asia, Europe and the United States. | 1 jaar |
| J. Daniel Clark | M | 78 | - | |
| Christopher P. Kafka | M | - | - | |
| Donald Taylor | M | - | - | |
| Samuel A. Lewis | M | - | 4 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 25 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- John J. DiPietro
- Persoonlijk netwerk
